Clinical Trial

Who can Join?

• Men aged 45 years or older
• Currently suffering from symptoms (frequent urination, painful or difficulty in urination, inability to empty bladder completely, etc.) associated with BPH
• Willingness to attend regular visits with the study doctors

What is the FloStent™*?

• Innovative, minimally invasive medical device
• Small, nitinol implant designed to relieve symptoms associated with BPH
• Implant procedure can be conducted in urologist’s office or surgery center

What to Expect?

‍
• The RAPID-3 Study involves a procedure performed by a trained and  certified urologist.
• The purpose of this study is to evaluate the safety and efficacy (effectiveness) of the FloStent™* in relieving symptoms of associated with BPH.
• According to available FloStent™* data, most men feel relief from BPH symptoms and are able to resume common lifestyle activities shortly after the procedure.
• Most previous FloStent™* recipients continue sexual function without burning  or irritation.

Why Participate?

• Your participation may contribute to the medical field’s knowledge of BPH and how best to treat it.
• The RAPID-3 Study will provide data for FDA review that may allow the FloStent™*  to be further used in the United States.
• Your participation may help you and other BPH patients.